F S&P 500
5,061.00 +13.50 (+0.27%) F Dow Jones
38,526.00 +58.00 (+0.15%) F Nasdaq
17,408.50 +58.50 (+0.34%) E-mini Russell 2000 Index Futur
1,981.60 -1.00 (-0.05%) Petróleo
81.34 -0.56 (-0.68%) Oro
2,315.70 -30.70 (-1.31%)
NovoCure Limited (NVCR)
Fuera de horario:
NovoCure Limited
No. 4 The Forum
Second Floor Grenville Street
Saint Helier JE2 4UF
Jersey
44 15 3475 6700
https://www.novocure.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 1,453
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. William F. Doyle | Executive Chairman | 1.52M | N/D | 1962 |
| Mr. Asaf Danziger | CEO & Director | 1.7M | N/D | 1966 |
| Ms. Ashley Cordova | Chief Financial Officer | 933.39k | 461.89k | 1979 |
| Mr. Wilhelmus C. M. Groenhuysen | Chief Operating Officer | 1.01M | N/D | 1958 |
| Mr. Frank Leonard | Executive VP & President of Novocure Oncology | 723.1k | 457.08k | N/D |
| Prof. Yoram Palti M.D., Ph.D. | Founder & CTO | 282.51k | N/D | 1938 |
| Dr. Moshe Giladi Ph.D. | Chief Science Officer | N/D | N/D | 1970 |
| Ms. Ingrid Goldberg | VP of Investor Relations | N/D | N/D | N/D |
| Mr. Barak Ben Arye | General Counsel | N/D | N/D | 1977 |
| Mr. Michael Puri | Chief Human Resources Officer | N/D | N/D | 1969 |
Descripción
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.
Gestión corporativa
La calificación ISS Governance QuickScore de NovoCure Limited a partir del 1 de abril de 2024 es 2. Las puntuaciones principales son Auditoría: 1; Junta: 4; Derechos del accionista: 3; Compensación: 4.
